Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Piers Blombery, Ella Thompson, Georgina L. Ryland, Rachel Joyce, David J. Byrne, Christine Khoo, Stephen Lade, Mark Hertzberg, Greg Hapgood, Paula Marlton, Anand Deva, Geoffrey Lindeman, Stephen Fox, David Westerman, Miles Prince
Published Nov 16, 2018 · Vol. 9, No. 90 · pp. 36126-36136
Tiffany J. Rios-Fuller, Gabriela Ortiz-Soto, Mercedes Lacourt-Ventura, Gerónimo Maldonado-Martinez, Luis A. Cubano, Robert J. Schneider, Michelle M. Martinez-Montemayor
Published Nov 13, 2018 · Vol. 9, No. 89 · pp. 35907-35921
Uri Rozovski, David M. Harris, Ping Li, Zhiming Liu, Preetesh Jain, Alessandra Ferrajoli, Jan Burger, Phillip Thompson, Nitin Jain, William Wierda, Michael J. Keating, Zeev Estrov
Published Sep 14, 2018 · Vol. 9, No. 72 · pp. 33710-33718
